Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nao, Inami"'
Autor:
Masato Karayama, Naoki Inui, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Kazuhiro Asada, Koji Nishimoto, Masato Fujii, Takashi Matsui, Shun Matsuura, Dai Hashimoto, Mikio Toyoshima, Masaki Ikeda, Hiroyuki Matsuda, Nao Inami, Yusuke Kaida, Satoshi Funayama, Shintaro Ichikawa, Satoshi Goshima, Takafumi Suda
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Immune-related pneumonitis (irP) is one of the most important immune-related adverse events caused by immune checkpoint inhibitors (ICIs). After corticosteroid therapy irP frequently relapses, which can interfere with cancer thera
Externí odkaz:
https://doaj.org/article/bb069103ab2445de9eae9f506ee87ea8
Autor:
Hiroyuki Matsuda, Yuzo Suzuki, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Takafumi Suda, Dai Hashimoto, Masaki Ikeda, Yusuke Inoue, Mikio Toyoshima, Yusuke Kaida, Hideki Yasui, Kazuhiro Asada, Tomohiro Uto, Masato Fujii, Takashi Matsui, Shun Matsuura, Nao Inami, Satoshi Funayama, Shintaro Ichikawa, Satoshi Goshima
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background There has been no prospective trial for treatment of immune-related pneumonitis (irP) occurred after immune checkpoint inhibitors (ICIs).Methods In this single-arm phase II study, patients with cancer with grade ≥2 irP received oral pred
Externí odkaz:
https://doaj.org/article/87a27195de9d45879814549aca29d5ee
Autor:
Yusuke Kaida, Naoki Inui, Kazuki Furuhashi, Yusuke Inoue, Tomohiro Uto, Katsuhiro Yoshimura, Kazutaka Mori, Noriyuki Enomoto, Mitsuru Niwa, Hiroyuki Matsuda, Shun Matsuura, Yuzo Suzuki, Yutaro Nakamura, Masato Fujii, Masato Karayama, Hironao Hozumi, Mikio Toyoshima, Yasuhiro Ito, Takafumi Suda, Dai Hashimoto, Tomoyuki Fujisawa, Hideki Kusagaya, Takashi Matsui, Nao Inami, Kazuhiro Asada
Publikováno v:
Cancer Immunology, Immunotherapy
Background Lipids have immunomodulatory functions and the potential to affect cancer immunity. Methods The associations of pretreatment serum cholesterol and long-chain fatty acids with the objective response rate (ORR), progression-free survival (PF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b30181e10d2c3235b65b6318b9a0a930
http://europepmc.org/articles/PMC8738455
http://europepmc.org/articles/PMC8738455
Autor:
Takafumi Koyauchi, Mikio Toyoshima, Yasuhiro Ito, Takafumi Suda, Mitsuru Niwa, Yuzo Suzuki, Kazuki Furuhashi, Yoshihiro Kitahara, Tomoyuki Fujisawa, Nao Inami, Hideki Yasui, Kazuhiro Asada, Yusuke Kaida, Hideki Kusagaya, Naoki Inui, Yusuke Amano, Hiroyuki Matsuda, Dai Hashimoto, Masato Karayama, Noriyuki Enomoto, Takashi Matsui, Yutaro Nakamura, Masato Fujii, Hironao Hozumi, Tomohiro Uto, Sho Takuma, Shun Matsuura
Publikováno v:
SN Comprehensive Clinical Medicine. 2:570-578
Immune checkpoint inhibitors have provided a breakthrough in cancer therapy. Pneumonitis related to immune checkpoint inhibitors is a serious immune-related adverse event that can be fatal. However, the response to corticosteroids and clinical course
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fbb88cc3da2ba83c047d364fced65f2
https://doi.org/10.1007/s42399-020-00259-3
https://doi.org/10.1007/s42399-020-00259-3
Autor:
Naoki Inui, Yutaro Nakamura, Masato Fujii, Mitsuru Niwa, Yasuhiro Ito, Masato Karayama, Takafumi Suda, Nao Inami, Hironao Hozumi, Yusuke Inoue, Kazuki Furuhashi, Hiroyuki Matsuda, Hideki Kusagaya, Dai Hashimoto, Mikio Toyoshima, Hideki Yasui, Yusuke Kaida, Katsuhiro Yoshimura, Koji Nishimoto, Haruhiko Sugimura, Noriyuki Enomoto, Shun Matsuura, Kazuhiro Asada, Tomoyuki Fujisawa, Takashi Matsui, Yuzo Suzuki, Tomohiro Uto
Publikováno v:
JAMA Netw Open
IMPORTANCE: Robust predictors for response to anti–programmed death 1 and its ligand (PD-1/PD-L1) immunotherapy in non–small cell lung cancer (NSCLC) are not fully characterized. OBJECTIVE: To evaluate whether PD-L1 (CD274) copy number gains (CNG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da87cba98e7cf13c5e0f824af4347f7
https://europepmc.org/articles/PMC7506518/
https://europepmc.org/articles/PMC7506518/
Autor:
Norimichi Akiyama, Noriyuki Enomoto, Hiroyuki Matsuda, Kazuki Furuhashi, Kazuhiro Asada, Takafumi Suda, Yuzo Suzuki, Shun Matsuura, Takashi Matsui, Naoki Inui, Masato Karayama, Mikio Toyoshima, Hideki Yasui, Tomohiro Uto, Nao Inami, Hironao Hozumi, Tomoyuki Fujisawa, Yutaro Nakamura, Masato Fujii, Yusuke Kaida
Publikováno v:
Investigational new drugs. 37(3)
Background Optimal maintenance therapy for lung squamous cell carcinoma (SCC) has not been established. The aim of this study was to evaluate the efficacy and safety of switch maintenance therapy with S-1, an oral fluoropyrimidine, after induction th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c33c1fb0df4c4747ecb21de62ec42834
https://pubmed.ncbi.nlm.nih.gov/30790149
https://pubmed.ncbi.nlm.nih.gov/30790149
Autor:
Shiro Imokawa, Naoki Inui, Yusuke Kaida, Yuzo Suzuki, Koji Nishimoto, Kazuhiro Asada, Masato Karayama, Hiroyuki Matsuda, Nao Inami, Tomoyuki Fujisawa, Takafumi Suda, Hironao Hozumi, Hideki Yasui, Yutaro Nakamura, Masato Fujii, Kazuki Furuhashi, Shun Matsuura, Noriyuki Enomoto, Takashi Matsui, Mikio Toyoshima
Publikováno v:
Medical oncology (Northwood, London, England). 35(7)
Switch maintenance therapy, using alternative agents that were not administered during induction chemotherapy, is a treatment option for advanced non-squamous non-small cell lung cancer (NSCLC). Bevacizumab is known to increase the efficacy of other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a9caa6389c5eac3352b9c7cd8c2ebc
https://pubmed.ncbi.nlm.nih.gov/29909581
https://pubmed.ncbi.nlm.nih.gov/29909581
Autor:
Tomoyoshi, Tsuchiya, Akifumi, Fujita, Hiroki, Ashizawa, Nao, Inami, Atsushi, Yoshitomi, Masafumi, Masuda, Takafumi, Suda, Kingo, Chida
Publikováno v:
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 49(7)
We evaluated the consistency of the A-DROP system for community-acquired pneumonia (CAP) and its outcomes, and developed a new severity classification of community-acquired pneumonia using nonlinear discriminant analysis. A total of 615 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f83091e113750ce79aad24702481b3d
https://pubmed.ncbi.nlm.nih.gov/21842684
https://pubmed.ncbi.nlm.nih.gov/21842684
[Case of pulmonary aspergilloma in the apices of both lungs which was associated with welder's lung]
Autor:
Hiroki, Ashizawa, Akifumi, Fujita, Nao, Inami, Tomoyoshi, Tsuchiya, Atsushi, Yoshitomi, Masafumi, Masuda, Yoshihiko, Kageyama, Hiroshi, Tsukamoto, Takafumi, Suda, Kingo, Chida
Publikováno v:
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 48(11)
A 48-year-old man, who had worked as a welder for 30 years, was admitted to our hospital with bloody sputum. His chest CT scan showed diffuse centrilobular micronodules and fungus balls within cavities in the apices of both lungs. We diagnosed pulmon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3fec7ae73827819bcebccf2ad1def31a
https://pubmed.ncbi.nlm.nih.gov/21141067
https://pubmed.ncbi.nlm.nih.gov/21141067